Brazil health regulator Anvisa allows Chinese COVID-19 vaccine trial

iStock [illustration]

Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.

Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.

According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.

It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.

More from International News

News

  • 'Peace is not far away' says Erdogan after Putin meeting

    Turkish President Tayyip Erdogan, fresh from a meeting with Russia's Vladimir Putin, said he hopes to discuss a Ukraine-Russia peace plan with US President Donald Trump, adding that "peace is not far away".

  • UAE, Serbia deepen ties with new political agreement

    His Highness Sheikh Abdullah bin Zayed Al Nahyan, UAE Deputy Prime Minister and Minister of Foreign Affairs, and Serbia’s Foreign Minister Marko Đurić. have agreed to deepen political coordination after signing a Memorandum of Understanding (MoU) during talks in Abu Dhabi.

  • UAE strengthens child protection measures

    The UAE has introduced changes to its laws governing the care of children of unknown parentage, expanding custody options and strengthening child protection measures.